Skip to main content
Home
  • Get Care
    • Find a Doctor
    • Request an Appointment
    • Virtual Visits
    • Locations & Directions
    • News
    • About Columbia Surgery
    • All Resources
  • Surgical Specialties
      • Adrenal
      • Aorta
      • Breast
      • Colorectal
      • Colorectal (Global Center)
      • Esophageal
      • Gall Bladder & Appendix
      • Gastric Cancer
      • Heart (Adult)
      • Heart (Pediatric)
      • Hernia
      • Kidney/Pancreas Transplantation
      • Liver Transplantation
      • Lung & Chest
      • Melanoma
      • Pancreas
      • Parathyroid
      • Pediatric/Neonatal
      • Plastic & Reconstructive
      • Robotic Surgery
      • Sarcoma
      • Thyroid
      • Vascular
      • Weight Loss Surgery
    • All Specialties
  • Research & Trials
    • About Research
    • About Clinical Trials
    • Basic & Translational Research
    • Cardiovascular Research
    • Clinical Research
    • Innovation & Outcomes Research
    • Translational Immunology Research
    • Transplant Research
    • All Research & Trials
  • Conditions & Treatments
      • Adrenal
      • Aortic
      • Breast
      • Colorectal
      • Esophageal
      • Gallbladder & Appendix (General Surgery)
      • Heart (Adult)
      • Hernia
      • Kidney
      • Liver
      • Lung & Chest (Thoracic)
      • Pancreas
      • Parathyroid
      • Pediatric (Neonatal)
      • Plastics (Cosmetic & Reconstructive)
      • Skin
      • Stomach (Gastric)
      • Thyroid
      • Vascular
      • Weight Loss (Bariatric)
    • All Conditions and Treatments
  • For Students and Professionals
  • Ways to Help
  • Request an Appointment

Search results

healthpoints Summer 2018

Last Modified: 02/13/2023 - 21:07

Multicenter, Randomized Phase 2B Study to Evaluate the Efficacy, Safety, and Tolerability of OCR-002 (Ornithine Phenylacetate) in Hospitalized Patients with Cirrhosis and Associated Hyperammonemia with an Episode of Hepatic Encephalopathy (STOP-HE)

… requiring hospitalization in cirrhotic patients. Trial Website: https://clinicaltrials.gov/show/NCT01966419 …

Last Modified: 02/13/2023 - 21:06

A Phase III Randomized, Controlled, Superiority Study Evaluating EVARREST Fibrin Sealant Patch Versus Standard of Care Treatment in Controlling Parenchymal Bleeding During Hepatic Surgery

… parenchymal bleeding during hepatic surgery. Trial Website: https://clinicaltrials.gov/show/NCT01993888 …

Last Modified: 02/13/2023 - 21:06

A 24 month, randomized, controlled, study to evaluate the efficacy and safety of concentration-controlled everolimus plus reduced tacrolimus compared to standard tacrolimus in recipients of living donor liver transplants

… in living donor liver transplant recipients. Trial Website: https://clinicaltrials.gov/show/NCT01888432 …

Last Modified: 02/13/2023 - 21:06

HCV-TARGET: Hepatitis C Therapeutic Registry and Research Network- A Longitudinal, Observational Study

… C (HCV) at both academic and community practices. Trial Website: https://clinicaltrials.gov/show/NCT01474811 …

Last Modified: 02/13/2023 - 21:06

Following The Dietary Guidelines for Americans May Reduce Your Risk for Pancreatic Cancer

… with pancreatic cancer this year, and over 38,000 will die. This poor prognosis largely results from the difficulty …

Last Modified: 02/23/2023 - 17:59

Waiting for a Kidney Transplant? Your chances for transplant could soon improve.

… – but more of its patients remain on the waitlist and die in the process. If programs really want to take care of …

Last Modified: 02/23/2023 - 17:59

History of Medicine: Leonardo Da Vinci and the Elusive Thyroid

… http://www.medscape.com/viewarticle/433848 … http://www.ncbi.nlm.nih.gov/pubmed/21120907 http://www.bbc.com/culture/story/20130828-leonardo-da-vinci-the-anatomist …

Last Modified: 02/23/2023 - 17:59

A 24-month, multi-center, single arm, prospective study to evaluate renal function, efficacy, safety and tolerability of everolimus in combination with reduced exposure cyclosporine or tacrolimus in paediatric liver transplant : CRAD001H2305

… CNI in paediatric liver transplant recipients. Trial Website: https://clinicaltrials.gov/show/NCT01598987 …

Last Modified: 02/13/2023 - 21:06

CTOTC Alloantibodies in Cardiac Transplantation: interventions, outcomes and mechanisms

… in nonsensitized heart transplant recipients. Trial Website: https://clinicaltrials.gov/show/NCT01005316 …

Last Modified: 02/13/2023 - 21:06

A Phase 3b study to evaluate the long-term outcomes following treatment with Abbvie DAAs and with or without Ribavirin (RBV) in adults with genotype 1 Chronic Hepatitis C Virus (HCV) Infection

… 1 Chronic Hepatitis C Virus (HCV) Infection. Trial Website: https://clinicaltrials.gov/show/NCT02167945 …

Last Modified: 02/13/2023 - 21:06

A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead-Sponsored Trials in Subjects with Chronic Hepatitis C Infection

… Gilead-sponsored hepatitis C virus (HCV) study. Trial Website: https://clinicaltrials.gov/show/NCT01457768 …

Last Modified: 02/13/2023 - 21:06

Prospective, Multi-Center, Open Label, Pilot Study of Safety and Efficacy of Triple Anti-Viral Therapy with Pegylated Interferon, Ribavirin, and Boceprevir in Patients with Genotype 1 Chronic HCV with End Stage Renal Disease

… end stage renal disease (ESRD) on hemodialysis (HD). Trial Website: https://clinicaltrials.gov/show/NCT02112630 …

Last Modified: 02/13/2023 - 21:06

A Phase 2, Multicenter, Open-Label Study to Investigate the Safety and Efficacy of Sofosbuvir/Ledipasvir Fixed-Dose Combination + Ribavirin Administered in Subjects Infected with Chronic HCV who have Advanced Liver Disease or are Post-Transplant

… dosing with the LDV/SOF FDC tablet+ribavirin (RBV). Trial Website: https://clinicaltrials.gov/show/NCT01938430 …

Last Modified: 02/13/2023 - 21:06

Pagination

  • « First First page
  • ‹‹ Previous page
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • ›› Next page
  • Last » Last page

Footer About

  • About Us
  • Request an Appointment
  • Virtual Visits
  • Organ Donation
  • Contact Us
  • Subscribe To Our Newsletter

Footer About 2

  • Directory
  • Alumni/JJSS
  • Locations & Directions
  • Ways to Help
  • Disclaimer
FOLLOW US
  • Twitter Logo
  • Facebook Logo
  • Youtube Logo
  • Instagram Logo
Visit
  • New York Presbyterian Logo
  • Columbia University Irving Medical Center Logo

©1999-2026. Columbia University Irving Medical Center, Department of Surgery, New York, NY.